Literature DB >> 15332432

Endocarditis in the setting of HIV infection.

Eulalia Valencia1, José Miró.   

Abstract

BACKGROUND: Cardiac complications are becoming more important in patients with HIV infection. The most common is infective endocarditis (IE) in patients who are intravenous drug addicts (IVDA). Other less common problems are pulmonary hypertension, cardiotoxicity, pericardial effusion, cardiac neoplasms, etc. PATIENTS AND METHODS: A literature review of published studies on IE was done and the personal experience of the authors is reflected.
RESULTS: The clinical pattern of IE has remained unchanged. It is usually due to Staphylococcus aureus and is more commonly localized to the right side of the heart. It is not clearly defined if HIV infection is responsible for the worst evolution in these patients and the treatment is the same as that used in HIV- subjects.
CONCLUSIONS: IE is responsible for 5-20% of hospital admissions and for 5-10% of total deaths in IVDA patients with HIV infection, but the clinical outcome of the patients depends on the affected valve and the culture germen rather than the HIV serostatus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15332432

Source DB:  PubMed          Journal:  AIDS Rev        ISSN: 1139-6121            Impact factor:   2.500


  3 in total

1.  Embolization of a huge tricuspid valve vegetation in a patient with intravenous drug abuse and HIV infection with an remarkable recovery.

Authors:  M El Abdouni; R Wardeh; M Scheffer
Journal:  Neth Heart J       Date:  2006-11       Impact factor: 2.380

2.  Tricuspid Endocarditis and Septic Pulmonary Embolism in an Intravenous Drug User with advanced HIV Infection.

Authors:  Kadriye Kart Yasar; Filiz Pehlivanoglu; Sevtap Gursoy; Gonul Sengoz
Journal:  Oman Med J       Date:  2011-09

3.  Multiple cause-of-death data among people with AIDS in Italy: a nationwide cross-sectional study.

Authors:  Enrico Grande; Antonella Zucchetto; Barbara Suligoi; Francesco Grippo; Marilena Pappagallo; Saverio Virdone; Laura Camoni; Martina Taborelli; Vincenza Regine; Diego Serraino; Luisa Frova
Journal:  Popul Health Metr       Date:  2017-05-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.